Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
sacituzumab govitecan
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
sacituzumab govitecan
Unique ID
C000608132
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000608132
Entry Term(s)
HRS7-SN38
IMMU-132
Trodelvy
Registry Numbers
M9BYU8XDQ6
Heading Mapped to
Camptothecin
/
analogs & derivatives
*Immunoconjugates
*Antibodies, Monoclonal, Humanized
Frequency
78
Note
a conjugate of RS7 monoclonal antibody and SN38; has antineoplastic activity
Source
Bioconjug Chem. 2015 May 20;26(5):919-31.
Date of Entry
2025/01/16
Revision Date
2025/01/16
Expand All
Collapse All
sacituzumab govitecan
Preferred
Concept UI
M000618569
Registry Numbers
M9BYU8XDQ6
Terms
sacituzumab govitecan
Preferred Term
Term UI
T000902374
Date
06/05/2016
LexicalTag
NON
ThesaurusID
IMMU-132
Narrower
Concept UI
M000618570
Terms
IMMU-132
Preferred Term
Term UI
T000902375
Date
06/05/2016
LexicalTag
LAB
ThesaurusID
NLM (2016)
HRS7-SN38
Narrower
Concept UI
M000654338
Terms
HRS7-SN38
Preferred Term
Term UI
T000965838
Date
08/20/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
Trodelvy
Narrower
Concept UI
M000768653
Terms
Trodelvy
Preferred Term
Term UI
T001146633
Date
01/16/2025
LexicalTag
NON
ThesaurusID
NLM (2025)
page delivered in 0.008s